Carl Genberg

Directeur Technique/Scientifique/R&D chez Ceragenix Corp.

72 ans

Consumer Services

Health Technology

Postes actifs de Carl Genberg

Sociétés	Poste	Début	Fin
Ceragenix Corp.	Directeur Technique/Scientifique/R&D	01/02/2002	-

Sociétés	Poste	Début	Fin
N8 Medical, Inc. N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019.	Directeur Général	-	01/06/2019
Ceragenix Pharmaceuticals, Inc. Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO.	Directeur Technique/Scientifique/R&D	01/05/2005	29/03/2010
OnSource Corp.	Corporate Officer/Principal	-	27/06/2005

Cornell University

Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1
Undergraduate Degree	1

Sectorielle

Consumer Services	3
Health Technology	3

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	4
OnSource Corp.	Consumer Services
Ceragenix Pharmaceuticals, Inc. Ceragenix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ceragenix Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on infectious disease and dermatology. It offers two base technologies: Ceragenins and Barrier Repair. The Ceragenins is used for the treatment of infectious disease and Barrier Repair Technology is used for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders and others. The company was founded in 2002 and is headquartered in Denver, CO.	Health Technology
Ceragenix Corp.
N8 Medical, Inc. N8 Medical, Inc. Medical SpecialtiesHealth Technology N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019.	Health Technology